Rezon Bio is a European biologics contract development and manufacturing organization (CDMO) that provides scalable, cost-efficient solutions for biologics programs. The company operates GMP-certified manufacturing sites in Warsaw and Gdańsk, Poland.
Subscribe to see Rezon Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Rezon Bio is a biotech company headquartered in Poland. Xcout tracks 9 named people at Rezon Bio, including Dr. Adriana Kiędzierska – Mencfeld (Chief Executive Officer).
3 more named people on record for Rezon Bio, with roles, board committees and tenure — see the full roster →
A few of Rezon Bio's closest competitors — see the full list of competitors and alternatives →
Mabion SA operates as a biotechnology company and Contract Development and Manufacturing Organization (CDMO) that provides services encompassing process development, analytics, and drug substance manufacturing. The company specializes in working with biologics such as biosimilars, antibodies, antibody-drug conjugates (ADCs), and recombinant therapeutic proteins to serve biopharmaceutical clients.
Biotechpharma is a contract development and manufacturing organization (CDMO) based in Vilnius, Lithuania. The company specializes in biopharmaceutical research and development, with a particular focus on recombinant protein technology.
Resilience Therapeutics, Inc. operates as a biomanufacturing contract development and manufacturing organization (CDMO) that provides drug substance and drug product manufacturing services for biologics and cell therapies. The company serves biopharmaceutical clients by offering end-to-end development, scale-up, fill/finish, and supply chain solutions to help commercialize complex medicines.
Zencore Biologics is a contract development and manufacturing organization (CDMO) headquartered in the Lin-gang New Area of the Shanghai Pilot Free Trade Zone in China. The company provides a one-stop CDMO services platform and operates an R&D facility in Maryland, United States.
Polpharma Biologics is a biotechnology company that develops and manufactures biosimilar medicines to improve patient access to biopharmaceuticals. Operating from Switzerland, the company manages a broad portfolio of biosimilars targeting major therapeutic areas and collaborates with global biopharmaceutical partners to bring these treatments from concept to commercial supply.
Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Rezon Bio? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.